Exact Mass: 494.4559528

Exact Mass Matches: 494.4559528

Found 170 metabolites which its exact mass value is equals to given mass value 494.4559528, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sporulenol

Sporulenol; (1R,2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-Hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]octadecahydrochrysen-2-ol

C35H58O (494.4487418)


   

N-Nervonoyl Glutamine

4-carbamoyl-2-(tetracos-15-enamido)butanoic acid

C29H54N2O4 (494.4083364)


N-nervonoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Nervonoyl Lysine

6-amino-2-(tetracos-15-enamido)hexanoic acid

C30H58N2O3 (494.44471980000003)


N-nervonoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Lysine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Secotenuifolide A

Secotenuifolide A

C31H58O4 (494.4334868)


   

11-hydroxytriacontan-2,13-dione

11-hydroxytriacontan-2,13-dione

C32H62O3 (494.46987019999995)


   

1-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

1-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

C31H58O4 (494.4334868)


   

(2R,3R)-3-Hydroxy-2-tetradecyl-octadec-11c-ensaeure|Corynomycolensaeure|D-erythro-3-hydroxy-2-tetradecyl-octadec-11c-enoic acid|D-erythro-3-Hydroxy-2-tetradecyl-octadec-11c-ensaeure

(2R,3R)-3-Hydroxy-2-tetradecyl-octadec-11c-ensaeure|Corynomycolensaeure|D-erythro-3-hydroxy-2-tetradecyl-octadec-11c-enoic acid|D-erythro-3-Hydroxy-2-tetradecyl-octadec-11c-ensaeure

C32H62O3 (494.46987019999995)


   
   
   
   
   

3-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

3-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

C31H58O4 (494.4334868)


   
   
   
   
   
   
   

(2Z,6Z,10Z,14Z,18E,22E)-3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaene-1-ol

(2Z,6Z,10Z,14Z,18E,22E)-3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaene-1-ol

C35H58O (494.4487418)


   

(2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydro-1H-chrysen-2-ol

(2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydro-1H-chrysen-2-ol

C35H58O (494.4487418)


   
   

N-Nervonoyl Glutamine

N-Nervonoyl Glutamine

C29H54N2O4 (494.4083364)


   

(-)-Duryne D

(-)-Duryne D

C34H54O2 (494.41235839999996)


An enyne that is (4E,13Z,19Z,30E)-tetratriaconta-4,13,19,30-tetraene-1,33-diyne substituted by hydroxy groups at positions 3 and 32 (the 3R,32R-stereoisomer). It has been isolated from the marine sponge Petrosia.

   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] butanoate

C31H58O4 (494.4334868)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] heptanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] heptanoate

C31H58O4 (494.4334868)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] hexanoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] hexanoate

C31H58O4 (494.4334868)


   

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] nonanoate

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] nonanoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] octanoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] octanoate

C31H58O4 (494.4334868)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] acetate

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] acetate

C31H58O4 (494.4334868)


   

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C31H58O4 (494.4334868)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] undecanoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] undecanoate

C31H58O4 (494.4334868)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C31H58O4 (494.4334868)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] decanoate

C31H58O4 (494.4334868)


   

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C31H58O4 (494.4334868)


   

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C31H58O4 (494.4334868)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C31H58O4 (494.4334868)


   
   
   

[3-carboxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropyl]-trimethylazanium

C30H56NO4+ (494.42091160000007)


   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-tetradec-9-enoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-tetradec-9-enoate

C34H54O2 (494.41235839999996)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoic acid

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoic acid

C34H54O2 (494.41235839999996)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

FAHFA 10:0/O-21:1

FAHFA 10:0/O-21:1

C31H58O4 (494.4334868)


   

FAHFA 10:1/O-21:0

FAHFA 10:1/O-21:0

C31H58O4 (494.4334868)


   

FAHFA 11:0/O-20:1

FAHFA 11:0/O-20:1

C31H58O4 (494.4334868)


   

FAHFA 11:1/O-20:0

FAHFA 11:1/O-20:0

C31H58O4 (494.4334868)


   

FAHFA 12:0/O-19:1

FAHFA 12:0/O-19:1

C31H58O4 (494.4334868)


   

FAHFA 12:1/O-19:0

FAHFA 12:1/O-19:0

C31H58O4 (494.4334868)


   

FAHFA 13:0/O-18:1

FAHFA 13:0/O-18:1

C31H58O4 (494.4334868)


   

FAHFA 13:1(12E)/12O-18:0

FAHFA 13:1(12E)/12O-18:0

C31H58O4 (494.4334868)


   

FAHFA 13:1/O-18:0

FAHFA 13:1/O-18:0

C31H58O4 (494.4334868)


   

FAHFA 14:0/O-17:1

FAHFA 14:0/O-17:1

C31H58O4 (494.4334868)


   

FAHFA 14:1/O-17:0

FAHFA 14:1/O-17:0

C31H58O4 (494.4334868)


   

FAHFA 15:0/O-16:1

FAHFA 15:0/O-16:1

C31H58O4 (494.4334868)


   

FAHFA 15:1(9Z)/3O-16:0

FAHFA 15:1(9Z)/3O-16:0

C31H58O4 (494.4334868)


   

FAHFA 15:1/O-16:0

FAHFA 15:1/O-16:0

C31H58O4 (494.4334868)


   

FAHFA 16:0/O-15:1

FAHFA 16:0/O-15:1

C31H58O4 (494.4334868)


   

FAHFA 16:1(9Z)/15O-15:0

FAHFA 16:1(9Z)/15O-15:0

C31H58O4 (494.4334868)


   

FAHFA 16:1/O-15:0

FAHFA 16:1/O-15:0

C31H58O4 (494.4334868)


   

FAHFA 17:0/O-14:1

FAHFA 17:0/O-14:1

C31H58O4 (494.4334868)


   

FAHFA 17:1(9Z)/2O-14:0

FAHFA 17:1(9Z)/2O-14:0

C31H58O4 (494.4334868)


   

FAHFA 17:1/O-14:0

FAHFA 17:1/O-14:0

C31H58O4 (494.4334868)


   

FAHFA 18:0/O-13:1

FAHFA 18:0/O-13:1

C31H58O4 (494.4334868)


   

FAHFA 18:1(9Z)/3O-13:0

FAHFA 18:1(9Z)/3O-13:0

C31H58O4 (494.4334868)


   

FAHFA 18:1/O-13:0

FAHFA 18:1/O-13:0

C31H58O4 (494.4334868)


   

FAHFA 19:0/O-12:1

FAHFA 19:0/O-12:1

C31H58O4 (494.4334868)


   

FAHFA 19:1(10Z)/3O-12:0

FAHFA 19:1(10Z)/3O-12:0

C31H58O4 (494.4334868)


   

FAHFA 19:1/O-12:0

FAHFA 19:1/O-12:0

C31H58O4 (494.4334868)


   

FAHFA 20:0/O-11:1

FAHFA 20:0/O-11:1

C31H58O4 (494.4334868)


   

FAHFA 20:1(11Z)/3O-11:0

FAHFA 20:1(11Z)/3O-11:0

C31H58O4 (494.4334868)


   

FAHFA 20:1/O-11:0

FAHFA 20:1/O-11:0

C31H58O4 (494.4334868)


   

FAHFA 21:0/O-10:1

FAHFA 21:0/O-10:1

C31H58O4 (494.4334868)


   

FAHFA 21:1/O-10:0

FAHFA 21:1/O-10:0

C31H58O4 (494.4334868)


   
   

FAHFA 22:1(13Z)/3O-9:0

FAHFA 22:1(13Z)/3O-9:0

C31H58O4 (494.4334868)


   
   
   

FAHFA 23:1(14Z)/3O-8:0

FAHFA 23:1(14Z)/3O-8:0

C31H58O4 (494.4334868)